Evidence map›Paper›PMID 27903959›Full record

ArticleOncotarget2017

Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.

Hongchao Lv, Mingming Zhang, Zhenwei Shang, Jin Li, Shanshan Zhang, Duan Lian, Ruijie Zhang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Replication of a GWAS signal nearBlood neoplasia · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. TowardsGenes · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells.International journal of molecular sciences · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hongchao LvCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Mingming ZhangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Zhenwei ShangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Jin LiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Shanshan ZhangHospital of Harbin Turbine Company Limited, Harbin Electric Corporation, Harbin, China.
Duan LianCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Ruijie ZhangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Harbin Medical University · CNHarbin Electric Corporation (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, and generally considered to be caused by environment and genetic factors. In this study, we combined a genome-wide haplotype association study (GWHAS) and gene prioritization strategy to mine AML-related genetic affect factors and understand its pathogenesis. A total of 175 AML patients were downloaded from the public GEO database (GSE32462) and 218 matched Caucasian controls were from the HapMap Project. We first identified the linkage disequilibrium (LD) blocks and performed a GWHAS to scan AML-related haplotypes. Then we mapped these haplotypes to the corresponding genes as candidate. And finally, we prioritized all the AML candidate genes based on the similarity with 38 known AML susceptibility genes. The results showed that 1754 haplotypes were significant associated with AML (P<1E-5) and mapped to 591 candidate genes. After prioritizing all 591 AML candidate genes, we obtained four genes ranking at the front as AML risk genes: RUNX1, JAK1, PDGFRA, and FGFR2. Among them, RUNX1, JAK1 and PDGFRA had been confirmed as AML risk genes. In particular, we found that the gene FGFR2 was a novel AML susceptibility gene with a haplotype TT (rs7090018 and rs2912759) showed significant association with AML (P-value = 7.07E-06). In a word, our findings might provide a new perspective to understand the pathogenesis of AML.

Indexed as

HaplotypesPolymorphism, Single NucleotideBiomarkers, TumorCase-Control StudiesComputational BiologyDatabases, GeneticGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansLeukemia, Myeloid, AcuteLinkage DisequilibriumPhenotypeReceptor, Fibroblast Growth Factor, Type 2Risk AssessmentRisk FactorsWhite PeopleBiomarkers, TumorFGFR2 protein, humanReceptor, Fibroblast Growth Factor, Type 2acute myeloid leukemiagene prioritizationhaplotype

Identifiers

PMID27903959
PMCPMC5352368
OpenAlexW2555146973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.